Cite
HARVARD Citation
Wanlapakorn, N. et al. (2022). Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study. Human vaccines & immunotherapeutics. 18 (1), p. . [Online].